Home/Filings/4/0001493152-25-002767
4//SEC Filing

Vizirgianakis Stavros G. 4

Accession 0001493152-25-002767

CIK 0000719135other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 4:07 PM ET

Size

6.0 KB

Accession

0001493152-25-002767

Insider Transaction Report

Form 4
Period: 2025-01-15
Transactions
  • Award

    Stock Option (Option to Buy)

    2025-01-15+50,00050,000 total
    Exercise: $1.42Exp: 2035-01-15Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]Issued pursuant to the Issuer's Director Compensation Program, as amended, which provides for the issuance of a stock option to non-employee directors with an exercise price equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Documents

1 file

Issuer

Apyx Medical Corp

CIK 0000719135

Entity typeother

Related Parties

1
  • filerCIK 0001559834

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:07 PM ET
Size
6.0 KB